Psilocybin (MycoMedia Life Sciences)

N/A

Report date: 2024/04/26 20:00:28

Base Information

Drug NamePsilocybin (MycoMedia Life Sciences)
Drug Alias NameMLS-101 (MycoMedia Life Sciences)MLS101 (MycoMedia Life Sciences)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 1a (5-HT1a) receptor agonistsSerotonin 2a (5-HT2a) receptor agonists
TargetsSerotonin 1a (5-HT1a) receptorSerotonin 2a (5-HT2a) receptor
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustraliaUnited Kingdom
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesMycoMedica Life Sciences PBC
China Registration ClassN/A

Develop Information

Active CompaniesMycoMedica Life Sciences PBC
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A